⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37113 | 0.79 | — | — | |
| Selenium SCHEMBL9160730 | 0.77 | — | — | |
| Furfural SCHEMBL11761016 | 0.76 | ALDH1A1 (0.82) | — | |
| SCHEMBL9454445 | 0.76 | — | — | |
| Furfural SCHEMBL2972777 | 0.75 | ALDH1A1 (0.78) | — | |
| Furfural SCHEMBL5695593 | 0.73 | ALDH1A1 (0.75) | — | |
| SCHEMBL641747 | 0.73 | ALDH1A1 (0.62) | — | |
| SCHEMBL490330 | 0.73 | ALDH1A1 (0.62) | — | |
| SCHEMBL2789580 | 0.73 | ALDH1A1 (0.62) | — | |
| SCHEMBL19665093 | 0.71 | ALDH1A1 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 798 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6372755-B1 | — | — | None | — | — | US | claimed |
| WO-2023217764-A1 | NOX INHIBITORS FOR USE IN THE TREATMENT OF ALPORT SYNDROME | CALLIDITAS THERAPEUTICS SUISSE SA (CH) | 2023-11-16 | — | — | WO | claimed |
| US-20210177811-A1 | USE OF NOX INHIBITORS FOR TREATMENT OF CANCER | CALLIDITAS THERAPEUTICS SUISSE SA (CH) | 2021-06-17 | — | — | US | claimed |
| EP-3703747-A1 | USE OF NOX INHIBITORS FOR TREATMENT OF CANCER | GenKyoTex Suisse SA (CH) | 2020-09-09 | — | — | EP | claimed |
| US-20180170903-A1 | PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | VIIV Healthcare UK (No.5) Limited (GB) | 2018-06-21 | — | — | US | claimed |
| EP-3319958-A1 | PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | VIIV Healthcare UK (No.5) Limited (GB) | 2018-05-16 | — | — | EP | claimed |
| EP-2356989-B1 | STABLE TABLET CONTAINING 4,5-EPOXYMORPHINAN DERIVATIVE | TORAY INDUSTRIES (JP) | 2018-02-07 | — | — | EP | claimed |
| EP-1758452-B1 | METABOLICALLY STABLE ANALGESICS AND PAIN MEDICATIONS | HUMAN BIOMOLECULAR RES INST (US) | 2017-01-25 | — | — | EP | claimed |
| WO-2017006261-A1 | PYRIDIN-3-YL ACETIC ACID DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | VIIV Healthcare UK (No.5) Limited (GB) | 2017-01-12 | — | — | WO | claimed |
| CN-105218516-A | Therapeutic compounds and related methods of use | OTSUKA PHARMA CO LTD | 2016-01-06 | — | — | CN | claimed |
| WO-1987006935-A1 | SUBSTITUTED PYRROLES WITH OPIOID RECEPTOR ACTIVITY | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1987-11-19 | — | — | WO | claimed |
| EP-0244018-A1 | Amino-thiazole and oxazole derivatives | AKZO N.V. (NL) | 1987-11-04 | — | — | EP | claimed |
| CN-87102879-A | Benzhydryl compounds as herbicide antidotes | — | 1987-10-28 | — | — | CN | claimed |
| CN-85101795-A | With 1, the two 2-oxyindoles that replace of 3-prepare pain killer and antiphlogistic | — | 1987-04-08 | — | — | CN | claimed |
| US-4649200-A | Substituted pyrroles with opioid receptor activity | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1987-03-10 | — | — | US | claimed |
| CN-85101029-A | The method of preparation-2-oxyindole-1-methane amide and intermediate product thereof | — | 1987-01-24 | — | — | CN | claimed |
| CN-85101028-A | Be used as the preparation of 2-oxyindole-1-methane amide that the 3-of anodyne and antiphlogistic replaces | — | 1987-01-17 | — | — | CN | claimed |
| US-4389410-A | Esters of monic acid A useful as antibacterial and antimycoplasmal agents | BEECHAM GROUP LIMITED (GB) | 1983-06-21 | — | — | US | claimed |
| US-4260762-A | NEUROLEPTICS | HOFFMANN-LA ROCHE INC. (US) | 1981-04-07 | — | — | US | claimed |
| US-3951962-A | ANTIBACTERIAL | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) | 1976-04-20 | — | — | US | claimed |